Brief: Karolinska Development's Portfolio Company Raises Capital Through Share Issue

Kdventures AB

14/07/2021 09:41

July 14 (Reuters) - Karolinska Development AB  KDEV.ST :
    * KAROLINSKA DEVELOPMENT’S PORTFOLIO COMPANY UMECRINE
COGNITION
RAISES CAPITAL THROUGH A SUCCESSFUL SHARE ISSUE
    * HAS CHOSEN TO CONVERT LOANS TOTALING SEK 66.9 MILLION INTO
SHARES IN UMECRINE COGNITION AT SAME SUBSCRIPTION PRICE AS IN
NEW SHARE ISSUE.
    * UMECRINE COGNITION HAS CARRIED OUT A DIRECTED NEW SHARE
ISSUE OF
SEK 35.1 MILLION TO BROADEN OWNERSHIP BASE AHEAD OF A PLANNED
IPO AND TO FINANCE CONTINUED CLINICAL DEVELOPMENT OF COMPANY'S
DRUG CANDIDATE GOLEXANOLONE.
    * THROUGH SHARE ISSUE, UMECRINE COGNITION WILL RECEIVE SEK
35.1
MILLION
    * FOLLOWING NEW SHARE ISSUE AND CONVERSION OF LOANS INTO
SHARES,
KAROLINSKA DEVELOPMENT'S OWNERSHIP INTEREST IN UMECRINE
COGNITION AMOUNTS TO 72.59 PERCENT.

Source text for Eikon:  ID:nGNE2SZ1G0 
Further company coverage:  KDEV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))